Orders for LABS from 'large traditional global pharma partner'??? Did their large traditional global pharmaceutical partner give LABS cannabinoid molecule production orders in Q4, 2023????????????????????????????????????????????????????
The FDA did say publicly that cannabinoids have application in a variety of human ailments including CANCER.
Well for the FDA to make that claim publicly they had to have the SCIENTIFIC EVIDENCE and CLINICAL TRIAL DATA to make that statement publicly and with LABS being the ONLY FDA approved source for pharmaceutical cannabinoids then it points to the scientific evidence and clincial data coming from cannabinoid pharmaceutical supplied by LABS and LABS did say they had over 20 strong clinical trials and most importantly when released publicly in the past, it too was said...MANY IN LATE STAGE.
So just wondering, did LABS receive any material orders from their global pharmaceutical partner??
When you connect the facts and knowledge base associated with LABS, it is then very possible that my question comes with a great deal of gravity.
One has to look carefully when at their financial cross roads...intended for those thinking the stock market is a casino game on their smart phone.
Have a nice night and if short, try not to have a tummy ache.